Measuring the expression level of PHF6 showed decreased PHF6 levels in patients with mutations compared to M0, M1, and M2 AML subtypes with wild-type PHF6, again supporting a tumor suppressor role for PHF6 and providing at least some genetic context to the results found by Mousa et al. Here, PHF6 is linked to acute myeloid leukemia.